Transforaminal lumbar interbody fusion and posterior lumbar interbody fusion utilizing BMP-2 in treatment of degenerative spondylolisthesis: Neither safe nor cost effective

Surgical Neurology International

Volumn 4, Issue SUPPL.2, 2013, Pages

  Moatz, Bradley ^a   Tortolani, P Justin ^a  

^a UNION MEMORIAL HOSPITAL   (United States)

Author keywords

Bone morphogenetic protein; cost effective; degenerative spondylolisthesis; interbody fusion device; quality adjusted life year

Indexed keywords

INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ANTERIOR SPINE FUSION; ARTICLE; BATTERED ROOT SYNDROME; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HETEROTOPIC OSSIFICATION; HUMAN; INTERBODY IMPLANT MIGRATION; INTERMETHOD COMPARISON; LUMBAR SPINAL STENOSIS; MEDICAL DEVICE COMPLICATION; NEUROLOGIC DISEASE; OFF LABEL DRUG USE; OSTEOLYSIS; PATIENT SAFETY; POSTERIOR SPINE FUSION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RADICULITIS; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELF REPORT; SIDE EFFECT; SPINAL CORD DECOMPRESSION; SPINE FUSION; SPINE STABILIZATION; SPONDYLOLISTHESIS; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 84877945099     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.109444     Document Type: Article

References (28)

1. Adogwa O, Parker SL, Davis BJ, Aaronson O, Devin C, Cheng JS, et al. Cost-effectiveness of transforaminal lumbar interbody fusion for Grade I degenerative spondylolisthesis. J Neurosurg Spine 2011;15:138-43.
2. Bowling S. Measuring health: A review of quality of life measurement scales. Buckingham, England: Open University Press; 1992.
3. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: Emerging safety concerns and lessons learned. Spine J 2011;11:471-91.
4. Chrastil J, Patel AA. Complications associated with posterior and transforaminal lumbar interbody fusion. J Am Acad Orthop Surg 2012;20:283-91.
5. Dall BE, Rowe DE. Degenerative spondylolisthesis. Its surgical management. Spine (Phila Pa 1976) 1985;10:668-72.
6. Deyo RA, Ching A, Matsen L, Martin BI, Kreuter W, Jarvik JG, et al. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: Trends, complications, repeat surgery, and charges. Spine (Phila Pa 1976) 2012;37:222-30.
7. Dobrow MJ, Goel V, Upshur RE. Evidence-based health policy: Context and utilisation. Soc Sci Med 2004;58:207-17.
8. Ekman P, Moller H, Tullberg T, Neumann P, Hedlund R. Posterior lumbar interbody fusion versus posterolateral fusion in adult isthmic spondylolisthesis. Spine (Phila Pa 1976) 2007;32:2178-83.
9. Fischgrund JS, Mackay M, Herkowitz HN, Brower R, Montgomery DM, Kurz LT. 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: A prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation. Spine (Phila Pa 1976) 1997;22:2807-12.
10. Fritzell P, Hagg O, Wessberg P, Nordwall A. Chronic low back pain and fusion: A comparison of three surgical techniques: A prospective multicenter randomized study from the Swedish lumbar spine study group. Spine (Phila Pa 1976) 2002;27:1131-41.
11. Ghogawala Z, Benzel EC, Amin-Hanjani S, Barker FG, Harrington JF, Magge SN, et al. Prospective outcomes evaluation after decompression with or without instrumented fusion for lumbar stenosis and degenerative Grade I spondylolisthesis. J Neurosurg Spine 2004;1:267-72.
12. Golish SR, DeHart MM. Principles and practice of statistics. In: Miller MD, editor. Review of Orthopaedics. 5 th ed. New York: Elsevier; 2008. p. 674-87.
13. Haid RW Jr., Branch CL Jr., Alexander JT, Burkus JK. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527-38.
14. Helgeson MD, Lehman RA Jr., Patzkowski JC, Dmitriev AE, Rosner MK, Mack AW. Adjacent vertebral body osteolysis with bone morphogenetic protein use in transforaminal lumbar interbody fusion. Spine J 2011;11:507-10.
15. Herkowitz HN, Kurz LT. Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis. J Bone Joint Surg Am 1991;73:802-8.
16. Inamdar DN, Alagappan M, Shyam L, Devadoss S, Devadoss A. Posterior lumbar interbody fusion versus intertransverse fusion in the treatment of lumbar spondylolisthesis. J Orthop Surg (Hong Kong) 2006;14:21-6.
17. Jones CA, Pohar S. Health-related quality of life after total joint arthroplasty: A scoping review. Clin Geriatr Med 2012;28:395-429.
18. Kim KT, Lee SH, Lee YH, Bae SC, Suk KS. Clinical outcomes of 3 fusion methods through the posterior approach in the lumbar spine. Spine (Phila Pa 1976) 2006;31:1351-7.
19. Kornblum MB, Fischgrund JS, Herkowitz HN, Abraham DA, Berkower DL, Ditkoff JS. Degenerative lumbar spondylolisthesis with spinal stenosis: A prospective long-term study comparing fusion and pseudarthrosis. Spine (Phila Pa 1976) 2004;29:726-33.
20. La Puma J, Lawlor EF. Quality-adjusted life-years. Ethical implications for physicians and policymakers. J Am Med Assoc 1990;263:2917-21.
21. Ong KL, Villarraga ML, Lau E, Carreon LY, Kurtz SM, Glassman SD. Off-label use of bone morphogenetic proteins in the United States using administrative data. Spine (Phila Pa 1976) 2010;35:1794-800.
22. Owens DK. Interpretation of cost-effectiveness analyses. J Gen Intern Med 1998;13:716-7.
23. Rampersaud YR, Ravi B, Lewis SJ, Stas V, Barron R, Davey R, et al. Assessment of health-related quality of life after surgical treatment of focal symptomatic spinal stenosis compared with osteoarthritis of the hip or knee. Spine J 2008;8:296-304.
24. Rihn JA, Patel R, Makda J, Hong J, Anderson DG, Vaccaro AR, et al. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J 2009;9:623-9.
25. Tso P, Walker K, Mahomed N, Coyte PC, Rampersaud YR. Comparison of lifetime incremental cost: Utility ratios of surgery relative to failed medical management for the treatment of hip, knee and spine osteoarthritis modelled using 2-year postsurgical values. Can J Surg 2012;55:181-90.
26. Vaidya R, Sethi A, Bartol S, Jacobson M, Coe C, Craig JG. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008;21:557-62.
27. Weinstein JN, Lurie JD, Olson PR, Bronner KK, Fisher ES. United States' trends and regional variations in lumbar spine surgery: 1992-2003. Spine (Phila Pa 1976) 2006;31:2707-14.
28. Weinstein JN, Lurie JD, Tosteson TD, Zhao W, Blood EA, Tosteson AN, et al. Surgical compared with nonoperative treatment for lumbar degenerative spondylolisthesis. Four-year results in the Spine Patient Outcomes Research Trial (SPORT) randomized and observational cohorts. J Bone Joint Surg Am 2009;91:1295-304.